GlassScriptPhysician profile
Susan M Rubin
NPI 1275046112
$7,673.91
in general payments reported to CMS, 2019-2025
13 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $3,240 · 2023: $3,570 · 2024: $229 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,729 · Consulting Fee: $1,440 · Travel and Lodging: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,728.90 |
| Consulting Fee | $1,440.00 |
| Travel and Lodging | $901.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $6,702.23 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $355.92 | 2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $186.79 | 2022-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $119.08 | 2023-2025 | Orthovisc, Monovisc |
| Endo Pharmaceuticals INC. | $83.38 | 2021 | |
| Globus Medical, INC. | $56.17 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $29.52 | 2025 | |
| Collegium Pharmaceutical, INC. | $28.97 | 2023 | Belbuca |
| Horizon Therapeutics Plc | $28.11 | 2021 | |
| Stryker Corporation | $23.99 | 2023 | Inspace |
| Pacira Therapeutics, INC. | $22.47 | 2021 | |
| Biodelivery Sciences International, INC. | $18.84 | 2021 | |
| Organogenesis INC. | $18.44 | 2025 | Nushield |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.